Fundamental analysis by بورس24 | Bourse24 about Stock دیران on 11/14/2023

✅ Increase in the rate in the "late" Iran Drug has announced that the sale rate of a number of its products has increased to cover the costs of raw material prices and based on the Food and Drug Administration licenses, according to Kodal Naga 24. The products announced in the Connection Table increased from 10% to 60%. 🔗 Read more ... @Bourse24ir